Clinical trials

  • DAPAGLIFLOZIN for Atrial fibrillation | Acute kidney injury | Chronic coronary syndrome (requiring CABG)
  • NEMOLIZUMAB for Atopic dermatitis
  • JNJ-87890387 for Advanced solid tumors
  • Trastuzumab deruxtecan for HER2-positive metastatic breast cancer
  • TOS-358 for Colorectal cancer | Cervical cancer | Endometrial cancer | Gastric cancer | Urothelial cancer | Breast cancer | Head and neck cancer | Ovarian cancer | Non-small cell lung cancer
  • Sacituzumab tirumotecan for Hormone receptor-positive (HR+) HER2-negative locally advanced or metastatic breast cancer
  • SEMAGLUTIDE for Type 2 diabetes | Diabetic foot ulcer
  • DURVALUMAB for Non-muscle invasive bladder cancer
  • BI 3720931 for Cystic fibrosis
  • STAR0602 for Unresectable, Locally Advanced, or Metastatic Solid Tumors
  • Triamcinolone acetonide for Esophageal strictures following esophageal atresia repair
  • STAR0602 for Unresectable locally advanced or metastatic solid tumors